Eli Lilly & Co. (LLY)

1025.47 +16.09 (+1.59%) USD  |  NYSE  |  Dec 12, 15:22
More

Eli Lilly EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for LLY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Amgen, Inc. --
Regeneron Pharmaceuticals, Inc. --
Adverum Biotechnologies, Inc. --
Viking Therapeutics, Inc. --
Moderna, Inc. --